Next Article in Journal
Behavioral and Chemical Ecology of Marine Organisms with Respect to Tetrodotoxin
Next Article in Special Issue
Novel Anti-Infective Compounds from Marine Bacteria
Previous Article in Journal
New Lobane and Cembrane Diterpenes from Two Comorian Soft Corals
Previous Article in Special Issue
Marine-Derived Metabolites of S-Adenosylmethionine as Templates for New Anti-Infectives
Article Menu

Export Article

Open AccessCommunication
Mar. Drugs 2010, 8(2), 373-380; doi:10.3390/md8020373

Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges

1
Julius-von-Sachs Institute for Biological Sciences, University of Würzburg, Julius-von-Sachs Platz 3, 97082 Würzburg, Germany
2
Research Center for Infectious Diseases, Josef-Schneider-Straße 2, 97080 Würzburg, Germany
3
Department of Medicinal Chemistry, University of Utah, Salt Lake City, 84112 Utah, USA
Present address: School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
*
Author to whom correspondence should be addressed.
Received: 26 December 2009 / Revised: 2 February 2010 / Accepted: 4 February 2010 / Published: 23 February 2010
(This article belongs to the Special Issue Marine Anti-infective Agents)
View Full-Text   |   Download PDF [183 KB, uploaded 24 February 2015]   |  

Abstract

Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC50 < 0.11 µM; staurosporine IC50 5.30 µM) and Trypanosoma brucei brucei (valinomycin IC50 0.0032 µM; staurosporine IC50 0.022 µM; butenolide IC50 31.77 µM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities. View Full-Text
Keywords: marine sponges; Streptomyces; valinomycin; staurosporine; butenolide; anti-parasitic marine sponges; Streptomyces; valinomycin; staurosporine; butenolide; anti-parasitic
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Pimentel-Elardo, S.M.; Kozytska, S.; Bugni, T.S.; Ireland, C.M.; Moll, H.; Hentschel, U. Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges. Mar. Drugs 2010, 8, 373-380.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top